Overall market sentiment has been down on Intercept Pharmaceuticals Inc (ICPT) stock lately. ICPT receives a Bearish rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With ICPT Stock Today?
Intercept Pharmaceuticals Inc (ICPT) stock is trading at $32.40 as of 3:28 PM on Monday, Oct 19, a loss of -$2.42, or -6.95% from the previous closing price of $34.82. The stock has traded between $32.17 and $35.16 so far today. Volume today is 753,167 compared to average volume of 746,609.
To see the top 5 stocks in the Biotechnology industry click here.
More About Intercept Pharmaceuticals Inc
Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor.
Click Here to get the full Stock Score Report on Intercept Pharmaceuticals Inc (ICPT) Stock.
